Skip to main content
Erschienen in: Annals of Surgical Oncology 5/2006

01.05.2006

Factors Influencing the Local Failure Rate of Radiofrequency Ablation of Colorectal Liver Metastases

verfasst von: Fredericke H. van Duijnhoven, MD, PhD, Maarten C. Jansen, MD, Jan M. C. Junggeburt, PhD, Richard van Hillegersberg, MD, PhD, Arjen M. Rijken, MD, PhD, Frits van Coevorden, MD, PhD, Joost R. van der Sijp, MD, PhD, Thomas M. van Gulik, MD, PhD, Gerrit D. Slooter, MD, PhD, Joost M. Klaase, MD, PhD, Hein Putter, PhD, Rob A. E. M. Tollenaar, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

The prognosis of patients with colorectal cancer is poor, especially when there is distant metastatic disease. Local ablation of tumor by radiofrequency ablation (RFA) has emerged as a safe and effective new treatment modality, but its long-term efficacy may be hindered by renewed local tumor growth at the site of RFA. The objectives of this study were to identify risk factors for local RFA failure and to define exclusion criteria for RFA treatment of colorectal liver metastases.

Methods

A total of 199 lesions in 87 patients were ablated with RFA. Factors influencing local failure rates were identified and compared with data from the literature.

Results

The local failure rate was 47.2%, and the average time to local disease progression was 6.5 months. Factors that significantly correlated with increased failure rates were metachronous occurrence of liver metastases, large mean lesion size, and central tumor location.

Conclusions

Because accurate electrode placement is pivotal in achieving adequate tumor necrosis, RFA should not be performed percutaneously when electrode placement is impaired. We suggest that lesions >5 cm and lesions located near great vessels or adjacent organs should be treated with open RFA, thus allowing vascular inflow occlusion and complete mobilization of the liver. Lesions that are difficult to reach by electrodes should be approached by an open procedure.
Literatur
1.
Zurück zum Zitat Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The National Cancer Data Base. Report on colon cancer. Cancer 1996; 78:918–26PubMed Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The National Cancer Data Base. Report on colon cancer. Cancer 1996; 78:918–26PubMed
2.
Zurück zum Zitat Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986; 150:195–203CrossRefPubMed Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986; 150:195–203CrossRefPubMed
3.
Zurück zum Zitat Welch JP, Donaldson GA. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979; 189:496–502PubMed Welch JP, Donaldson GA. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979; 189:496–502PubMed
4.
Zurück zum Zitat Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938–46PubMed Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938–46PubMed
5.
Zurück zum Zitat Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg 1989; 124:1021–2PubMed Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg 1989; 124:1021–2PubMed
6.
Zurück zum Zitat Bilchik AJ, Rose DM, Allegra DP, Bostick PJ, Hseuh E, Morton DL. Radiofrequency ablation: a minimally invasive technique with multiple applications. Cancer J Sci Am 1999; 5:356–61PubMed Bilchik AJ, Rose DM, Allegra DP, Bostick PJ, Hseuh E, Morton DL. Radiofrequency ablation: a minimally invasive technique with multiple applications. Cancer J Sci Am 1999; 5:356–61PubMed
7.
Zurück zum Zitat de Baere T, Elias D, Ducreux M, et al. Percutaneous radiofrequency of liver metastases: single center experience over a five year period (abstract). Proc Am Soc Clin Oncol 2003; 1387:345 de Baere T, Elias D, Ducreux M, et al. Percutaneous radiofrequency of liver metastases: single center experience over a five year period (abstract). Proc Am Soc Clin Oncol 2003; 1387:345
8.
Zurück zum Zitat Jiao LR, Hansen PD, Havlik R, Mitry RR, Pignatelli M, Habib N. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg 1999; 177:303–6CrossRefPubMed Jiao LR, Hansen PD, Havlik R, Mitry RR, Pignatelli M, Habib N. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg 1999; 177:303–6CrossRefPubMed
9.
Zurück zum Zitat Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003; 90:1240–3CrossRefPubMed Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003; 90:1240–3CrossRefPubMed
10.
Zurück zum Zitat Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003; 10:1059–69CrossRefPubMed Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003; 10:1059–69CrossRefPubMed
11.
Zurück zum Zitat Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin North Am 2003; 12:243–55 Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin North Am 2003; 12:243–55
12.
Zurück zum Zitat Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221:159–66PubMed Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221:159–66PubMed
13.
Zurück zum Zitat Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33:1124–9CrossRefPubMed Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33:1124–9CrossRefPubMed
14.
Zurück zum Zitat Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004; 239:450–8PubMed Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004; 239:450–8PubMed
15.
Zurück zum Zitat Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226:441–51PubMed Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226:441–51PubMed
16.
Zurück zum Zitat de Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003; 181:695–700PubMed de Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003; 181:695–700PubMed
17.
Zurück zum Zitat Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002; 89:1206–22CrossRefPubMed Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002; 89:1206–22CrossRefPubMed
18.
Zurück zum Zitat Livraghi T, Solbiati L, Meloni MF, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach.” Cancer 2003; 97:3027–35CrossRefPubMed Livraghi T, Solbiati L, Meloni MF, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach.” Cancer 2003; 97:3027–35CrossRefPubMed
19.
Zurück zum Zitat Goldberg SN, Charboneau JW, Dodd GD III, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228:335–45PubMed Goldberg SN, Charboneau JW, Dodd GD III, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228:335–45PubMed
20.
Zurück zum Zitat Lin DY, Wei LJ. Robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989; 84:1074–8 Lin DY, Wei LJ. Robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989; 84:1074–8
21.
Zurück zum Zitat Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 2003; 28:192–7PubMed Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 2003; 28:192–7PubMed
22.
Zurück zum Zitat Donckier V, van Laethem JL, Goldman S, et al. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 2003; 84:215–23PubMed Donckier V, van Laethem JL, Goldman S, et al. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 2003; 84:215–23PubMed
23.
Zurück zum Zitat Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230:1–8CrossRefPubMed Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230:1–8CrossRefPubMed
24.
Zurück zum Zitat Machi J, Uchida S, Sumida K, et al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg 2001; 5:477–89CrossRefPubMed Machi J, Uchida S, Sumida K, et al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg 2001; 5:477–89CrossRefPubMed
25.
Zurück zum Zitat Oshowo A, Gillams AR, Lees WR, Taylor I. Radiofrequency ablation extends the scope of surgery in colorectal liver metastases. Eur J Surg Oncol 2003; 29:244–7CrossRefPubMed Oshowo A, Gillams AR, Lees WR, Taylor I. Radiofrequency ablation extends the scope of surgery in colorectal liver metastases. Eur J Surg Oncol 2003; 29:244–7CrossRefPubMed
26.
Zurück zum Zitat Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202:195–203PubMed Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202:195–203PubMed
27.
Zurück zum Zitat Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000; 7:593–600PubMed Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000; 7:593–600PubMed
28.
Zurück zum Zitat Sjolie E, Lango T, Ystgaard B, Tangen GA, Nagelhus Hernes TA, Marvik R. 3D ultrasound-based navigation for radiofrequency thermal ablation in the treatment of liver malignancies. Surg Endosc 2003; 17:933–8PubMed Sjolie E, Lango T, Ystgaard B, Tangen GA, Nagelhus Hernes TA, Marvik R. 3D ultrasound-based navigation for radiofrequency thermal ablation in the treatment of liver malignancies. Surg Endosc 2003; 17:933–8PubMed
29.
Zurück zum Zitat Stippel DL, Bohm S, Beckurts KT, Brochhagen HG, Holscher AH. Experimental evaluation of accuracy of radiofrequency ablation using conventional ultrasound or a third-dimension navigation tool. Langenbecks Arch Surg 2002; 387:303–8CrossRefPubMed Stippel DL, Bohm S, Beckurts KT, Brochhagen HG, Holscher AH. Experimental evaluation of accuracy of radiofrequency ablation using conventional ultrasound or a third-dimension navigation tool. Langenbecks Arch Surg 2002; 387:303–8CrossRefPubMed
30.
Zurück zum Zitat Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14:1267–74PubMed Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14:1267–74PubMed
31.
Zurück zum Zitat Wiersinga WJ, Jansen MC, Straatsburg IH, et al. Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver. Br J Surg 2003; 90:306–12CrossRefPubMed Wiersinga WJ, Jansen MC, Straatsburg IH, et al. Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver. Br J Surg 2003; 90:306–12CrossRefPubMed
32.
Zurück zum Zitat Arata MA, Nisenbaum HL, Clark TW, Soulen MC. Percutaneous radiofrequency ablation of liver tumors with the LeVeen probe: is roll-off predictive of response? J Vasc Interv Radiol 2001; 12:455–8PubMed Arata MA, Nisenbaum HL, Clark TW, Soulen MC. Percutaneous radiofrequency ablation of liver tumors with the LeVeen probe: is roll-off predictive of response? J Vasc Interv Radiol 2001; 12:455–8PubMed
33.
Zurück zum Zitat Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcome following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239:818–25PubMed Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcome following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239:818–25PubMed
34.
Zurück zum Zitat Choy PY, Koea J, McCall J, et al. The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned. N Z Med J 2002; 115:U128PubMed Choy PY, Koea J, McCall J, et al. The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned. N Z Med J 2002; 115:U128PubMed
Metadaten
Titel
Factors Influencing the Local Failure Rate of Radiofrequency Ablation of Colorectal Liver Metastases
verfasst von
Fredericke H. van Duijnhoven, MD, PhD
Maarten C. Jansen, MD
Jan M. C. Junggeburt, PhD
Richard van Hillegersberg, MD, PhD
Arjen M. Rijken, MD, PhD
Frits van Coevorden, MD, PhD
Joost R. van der Sijp, MD, PhD
Thomas M. van Gulik, MD, PhD
Gerrit D. Slooter, MD, PhD
Joost M. Klaase, MD, PhD
Hein Putter, PhD
Rob A. E. M. Tollenaar, MD, PhD
Publikationsdatum
01.05.2006
Erschienen in
Annals of Surgical Oncology / Ausgabe 5/2006
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/ASO.2006.08.014

Weitere Artikel der Ausgabe 5/2006

Annals of Surgical Oncology 5/2006 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.